ONCODESIGN SA has a total of 78 patent applications. It decreased the IP activity by 88.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are CHEMBRIDGE CORP, NANTBIOSCIENCE INC and PHENEX PHARMACEUTICALS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | United States | 7 | |
#3 | Canada | 6 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Australia | 5 | |
#6 | China | 5 | |
#7 | Israel | 5 | |
#8 | Republic of Korea | 5 | |
#9 | Mexico | 5 | |
#10 | Brazil | 4 | |
#11 | Singapore | 4 | |
#12 | EAPO (Eurasian Patent Organization) | 3 | |
#13 | United Kingdom | 3 | |
#14 | Hong Kong | 3 | |
#15 | Hungary | 3 | |
#16 | South Africa | 3 | |
#17 | Taiwan | 2 | |
#18 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Hoflack Jan Marie Cyriel Jozef | 37 |
#2 | Hoflack Jan | 24 |
#3 | Blom Petra Marcella Francoise | 24 |
#4 | Blom Petra | 23 |
#5 | Gomez Sylvie | 13 |
#6 | Blom Petra Marcella Françoise | 13 |
#7 | Benderitter Pascal | 12 |
#8 | Lavergne Olivier | 11 |
#9 | Benderitter Pascal Andre Rene | 11 |
#10 | Benderitter Pascal André René | 10 |
Publication | Filing date | Title |
---|---|---|
WO2017148925A1 | Radiolabeled macrocyclic egfr inhibitor | |
WO2016146651A1 | Macrocyclic activin-like receptor kinase inhibitors | |
CA2958782A1 | Macrocyclic rip2 kinase inhibitors | |
WO2016042089A1 | Macrocyclic lrrk2 kinase inhibitors | |
WO2015136073A1 | Macrocyclic tgf-br2 kinase inhibitors | |
GB201404570D0 | Macrocyclic kinase inhibitors | |
EP2968325A1 | Macrocyclic rip2 kinase inhibitors | |
GB201404555D0 | Macrocyclic kinase inhibitors | |
CA2906257A1 | Macrocyclic rip2 kinase inhibitors | |
BR112015022650A2 | macrocyclic salt inducible kinase inhibitors. | |
EP2968326A1 | Macrocyclic salt-inducible kinase inhibitors | |
GB201304714D0 | Macrocyclic RIP2 Kinase inhibitors | |
EP2760867A1 | Macrocyclic flt3 kinase inhibitors | |
CN103930427A | Macrocyclic FLT3 kinase inhibitors |